Last reviewed · How we verify
NCT06740409: AVE-MREMS
Accuracy and External Validation of mREMS in Road Traffic Injuries
trial in Trauma in 292 participants. Completed in 15 January 2026.
1 January 2026
Quick facts
| Lead sponsor | Al-Nahrain University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 292 |
| Start date | 20 December 2024 |
| Primary completion | 1 January 2026 |
| Estimated completion | 15 January 2026 |
| Sites | 1 location across Iraq |
Conditions studied
- Trauma — all drugs for Trauma →
Sponsor
Al-Nahrain University
Who can join
18 and older, any sex, with Trauma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this prospective observational study is to assess the accuracy and external validation of the Modified Rapid Emergency Medicine Score (mREMS) in predicting outcomes for patients with road traffic injuries (RTIs) admitted to the emergency department of a hospital in Baghdad. The main questions it aims to answer are: How accurate is the mREMS in predicting the prognosis of road traffic injury patients? Does the mREMS provide reliable predictive value in a local context, specifically in Baghdad? Participants will: Be assessed using the mREMS upon admission to the emergency department. Have their clinical outcomes, including mortality, need for surgery, and length of stay, monitored throughout their hospital stay.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06740409
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Trauma
Currently open trials in the same condition.
- NCT07290634 — Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion · recruiting
- NCT07485231 — Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD · NA · recruiting
- NCT07473336 — The Effectiveness of RAPID-Based Psychological First Aid Training · NA · active not recruiting
- NCT07278505 — Study of Cannabidiol and Neuroimaging on Stress · Phase 1, PHASE2 · recruiting
- NCT02880163 — REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam · NA · recruiting
Other Al-Nahrain University trials
Trials by the same sponsor.
- NCT07437664 — A Computer-Aided Design Approach for Customized Soft Transradial Prosthetic Sockets Using 3D Scanning · NA · active not recruiting
- NCT07186777 — Comparison of EMTRAS, REMS, and GAP Scores in Trauma · recruiting
- NCT06744959 — Thorax Trauma Severity Score in Chest Trauma: A Study in Iraq · recruiting
- NCT06705959 — Comparing NISS and ISS for Mortality Prediction in Trauma Patients · recruiting
- NCT06732752 — Evaluating the New Trauma Score (NTS) for Improved Mortality Prediction · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06740409 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Al-Nahrain University
- Last refreshed: 4 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06740409.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing